Search:

Intellectual Property Valuation Resource Center
Welcome to the IP resource center - your one-stop shop for key information and tools for valuing intellectual property.

 
Save the Dates!
BVR/Morningstar Best Practices in Valuing Intellectual Property: An International Look

September 15-16, 2010 | Chicago, IL

IP Blog Feed:

Law and finance meet in IP valuation event in Chicago in two weeks

Expert insights on intellectual property valuation and economic analysis

How would you value this patent?

How to improve your early stage IP valuations

The current state of the patent marketplace – an attorney’s view

If you can win on this IP claim, you can win on anything

BVR’s Guide to Intellectual Property Valuation updated

‘Plausible’ patent infringement analysis needs more to support lost profits award

How to make a few pennies from your copyrights…with bottom-feeding Righthaven

 

Previous News Items


 

 Understanding the best practices in IP valuation is essential for allocating acquisitions, avoiding asset impairments, and maximizing royalties and business relationships from your intangible assets.  This first-ever event offers the opportunity to meet one on one with the regulators and other thought leaders in IP valuation.

Learn More
Register Today - Call (503) 291-7963 for special pricing

 

Royalty Rates in Biotech

 

Royalty Rates in Copyright Agreements:
A BVR Guide to Full-Text Licensing Agreements

For an owner of intellectual property rights, “managing” that intellectual property is now the operative demand — in an uncertain … or certainly sluggish … economy, organizations need to know where to allocate precious resources. And the first step to “managing” IP is ascertaining its value.

There are several treatises on valuing trademarks and trade names … still more on valuing patents. Up until now, very little has been assembled to assist in the valuation of an organization’s copyright assets. Through the transfer of copyright intellectual property rights, creators monetize their works. The two most common types of copyright transfers are assignments and licenses. Royalty Rates in Copyright Agreements illustrates how others have realized value from their copyrights through licensing.

By looking at the licenses others have negotiated, readers can gain empirical insight into relative values of these intellectual properties. The full text licenses contained herein contain non-redacted variable or “running” royalty rates. Each agreement is first summarized and then provided in full text. This one-of-a-kind guide features over 800 pages of agreements and summaries, including agreements for music, movie, character/personas, scientific/technological information and more.

Preview Table of Contents

Order Book for $595.00 + S&H

 

Royalty Rates in Biotech Just Published! Royalty Rates in Biotech: BVR’s Guide to Full-Text Licensing Agreements

Intellectual property valuations occur in the biotech industry for a number of reasons, including licensing, transfer pricing, mergers and acquitions, collateral and litigation. In order to make an agreement to license intellectual property rights (IPR), either incoming or outgoing, the parties must know as accurately as possible the real value of the IPR. Additionally, some licensing agreements specifically address non-cash, non-equity exchanges, calling for fair market valuations of the assets exchanged.

To assist in constructing these agreements, BVR has published the Royalty Rates in Biotech guide, which contains over 500 pages of full text copies of actual licensing agreements in the biotech industry. These hard-to-find agreements will provide valuable guidance in setting royalty rates and addressing complex issues in a license agreement.

Preview Table of Contents

Order Book for $595.00 + S&H

 

BVR's Guide to Intellectual Property Valuation
Authored by: Mike Pellegrino

This Guide is the definitive reference to draw credible and defensible IP value conclusions. Leading expert Michael Pellegrino delivers real-world case studies of IP valuation analyses from start to finish in each of the primary IP categories. This practical, hands-on Guide presents an objective framework for conducting due diligence of IP rights, performing the legal analysis, and correlating the impacts of IP rights on value.

The Online Guide allows 24/7 access from any Internet connection and the advantage of real time updates such as recently published court opinions that involve IP, new articles by the author as well as other leading experts, conference presentations, podcasts, news and blog feeds, and much more! Plus, the Online Guide is available in digital format and can be loaded onto any eBook reader.

Preview Online Version & Table of Contents

Order Book for $199.00 + S&H | Order Book & Online Version for $329.00 + S&H

 

Calculating Lost Profit in IP and Patent Infringement Cases
Authored by Nancy J. Fannon

This 690-page Guide and companion online resource center brings together the comprehensive body of knowledge on lost profits damages and delivers a definitive resource for IP professionals, tech transfer execs, financial experts, and attorneys. Written by Nancy Fannon, owner of Fannon Valuation Group, and other industry leading experts, Calculating Lost Profits delivers a thorough analysis of current case law and valuation methodology that form the basis of damage awards in IP and patent infringement cases. It includes a thorough overview of lost profits damages in Patent Infringement, Trademark, and Copyright Cases; Daubert and other motions to exclude financial experts in lost profits cases outlined by federal jurisdiction and by state; discussion of methodology used to determine lost profits damages, including what evidence is required to support the damage claim; Expert analysis of relevant case law; an overview of the U.S. Court system that tracks a claim from initiation through discovery and appeal; and an extensive chapter on the rules of evidence and discovery and the rules relating to spoliation of evidence.

The Online Guide allows 24/7 access from any Internet connection and the advantage of real time updates such as recently published court opinions that involve IP, new articles by the author as well as other leading experts, conference presentations, podcasts, news and blog feeds, and much more! Plus, the Online Guide is available in digital format and can be loaded onto any eBook reader.

Preview Online Version | Preview Table of Contents

Order Book for $199.00 + S&H | Order Book & Online Version for $329.00 + S&H

 

ktMINE Database

This interactive intellectual property database provides direct access to royalty rates, actual license agreements and detailed agreement summaries. With precise search functionality and robust data mining capabilities, ktMINE lets you quickly find and analyze market comparables from a goldmine of IP license agreements and documents.

It includes more than 6,000 non-redacted license agreements with royalty rate data are searchable today, growing by 200 new agreements every month. It's the most authoritative and cost effective tool of its kind and offers unlimited searches, for one low price. Analysts control their costs, and ktMine facilitates pass-through of the expense.

For more information, please visit: www.BVMarketData.com or contact Randy Cochran randyc@bvresources.com

 

Desktop Learning Center
Desktop Learning Center materials include a CD with the audio recording of the teleconference, transcript, and all presentation and ancillary reading materials. CPE is not available.

  • Fair Value Summit: Intellectual Property Valuation Session - $149.00
    Panel includes: Mike Pellegrino, Tom Miller, David Dufendach, Brad Pursel, and Mike Taylor

    At BVR's 3rd Annual Summit on Fair Value for Financial Reporting top practitioners in this dynamic and ever important field taught attendees how they comply with FAS 157 and related regulations, with special focus on the timely issues in impairment testing, purchase price allocation, stock options, debt instrument valuation, and more. In this intense, two-hour, fifteen-minute workshop, the experts discuss everything needed to know when valuing early stage intellectual property. If you’re doing these valuations, or are approaching fair value standards in financial reporting, you can’t afford to miss this presentation.

  • An IP Cost of Capital Estimation Model - $99.00
    Panel includes: Mike Pellegrino, Rob Schlegel and Neil Beaton


    Whereas many IP cost of capital estimations are adjusted using little more than the appraiser’s experience, Mike Pellegrino has developed a model that captures the unique attributes of IP using objective empirical evidence. Joining Pellegrino were valuation experts Rob Schlegel and Neil Beaton who put this model under close scrutiny as they test its validity and applicability. For anyone challenged with assessing discounts rates for IP valuations, this presentation is a must.


  • Valuing Intellectual Property in Entertainment and the Arts - $99.00
    Panel includes: Kevin Yeanoplos, Bill Sipes and Mike Pellegrino


    Intellectual property represents both opportunities and challenges for appraisers: creating a large amount of often difficult work. In entertainment and the arts, however, these two facts are changing rapidly. New technology is making distribution easier, thereby undercutting older economies of scale; transactions and other valuations involving artistic catalogues are increasing along with complications and considerations in the valuation process. The panel covers what every valuation analyst needs to know when called to appraise a catalogue of music, literature, film, or any other medium in today’s environment.


  • SPECIAL OFFER - Intellectual Property Desktop Learning Program Package - $199.00 (you save $148.00!)
    This valuable package includes all fo the IP programs
    • Fair Value Summit: Intellectual Property Valuation Session
    • An IP Cost of Capital Estimation Model
    • Valuing Intellectual Property in Entertainment and the Arts

Royalty Rates for Technology, 4th Edition
(Delivered via email as PDF)

This edition of Royalty Rates for Technology reports all available compensation terms for the license agreements we discovered. We report fixed royalty rates, per unit royalties, scaled royalty rates, and license fees. For each transaction in this book we report:

  • A description of the licensed technologyCompensation terms including royalty rates and license feesIdentity of the licensor and licensee
  • For many deals, we also discuss the markets for and benefits of the licensed technology

In addition to royalty rates from real deals, we provide Royalty Rate Derivation Models, showing different methods for calculating appropriate royalty rates and royalty audit advice to assure compliance with license agreements and the accurate collection of royalty payments

Order Book for $1250.00 (delivered as PDF via email)

 

Royalty Rates for Trademarks & Copyrights - Fourth Edition
(Delivered as PDF via email)

Royalty Rates for trademarks and copyrights are at the heart of this new edition. Financial models for determining a royalty rate are a new part of this new edition. Included in this book is a description of rules of thumb, profit differential calculations, investment rate of return analyses and discounted cash flow analysis. Examples are presented that can be used as a template for your specific applications. Royalty Rate data is reported in industries such as airlines, celebrities, electronics, publishing, sports, and more.

Order book for $600 (delivered as PDF via email)

 

Royalty Rates for IP Rates for Pharmaceuticals & Biotechnology
(Delivered as PDF via email)

This Guide reports royalty rates for an incredible range of compounds, manufacturing techniques, therapies and other pharmaceutical and biotechnology patented inventions.

Just some of the technology categories covered include attention deficit disorder, Alzheimer’s detection, anti-inflammatory, antifungal, antiviral, arthritis, bone marrow production, cancer, cardiovascular, cartilage regeneration, chromosome analysis, cold remedies, contraception, cystic fibrosis, dermatology, diabetes, drug delivery, gene alteration, hepatitis, HIV, humanized antibodies, monoclonal antibodies, neurological, pain therapy, personal care, psychotherapy, research processes, sleep therapy, stem cells, transdermal drug delivery, and vaccines.

It presents detailed financial information about third party transactions that center on the transfer of biotechnology and pharmaceutical technology. The parties are identified, the technology is described and all of the financial terms available are reported including royalty rates, license fees and milestone payments. This new edition also presents seven financially based models for pricing and valuing biotech and pharmaceutical technology and comprehensive illustrations are provided.

Order book for $1750 (delivered as PDF via email)

 

 

Copyright © 2010 Business Valuation Resources, LLC. All rights reserved.
1000 SW Broadway, Suite 1200
Portland, OR 97205
(888) BUS-VALU, (503) 291-7963

« Top